Sirisha L Mushti

4PUBLICATIONS
35CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 29, 2024
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.

Michael J Fusco, Sandra J Casak, Sirisha L Mushti

|Jun 08, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements.

Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti

|Dec 09, 2022
FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor.

Vaibhav Kumar, Leslie Doros, Margaret Thompson

Pageof 1